Physician profile
William J David
NPI 1851497242
$14,736.36
in general payments reported to CMS, 2019-2025
37 companies · $1,772 in 2025
The $1,772 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $615 · 2021: $1,513 · 2022: $1,664 · 2023: $5,666 · 2024: $2,153 · 2025: $1,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,067 · Consulting Fee: $3,150 · Travel and Lodging: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,067.22 |
| Consulting Fee | $3,150.00 |
| Travel and Lodging | $374.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,342.68 | 2019-2025 | |
| Abiomed | $2,760.00 | 2019-2025 | Impella |
| Abbott Laboratories | $1,469.23 | 2021-2025 | Aveir, Cardiomems |
| Janssen Pharmaceuticals, INC | $555.47 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $506.99 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $482.01 | 2021-2025 | Verquvo, Belsomra |
| Cvrx, INC. | $438.50 | 2022-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $419.63 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $322.18 | 2019-2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $313.06 | 2024 | Inpefa |
| Philips North America LLC | $294.42 | 2021-2025 | Azurion 7 M20, Azurion 7 M12, Ecc Solutions |
| Ge Healthcare | $224.65 | 2025 | |
| Esperion Therapeutics, INC. | $182.10 | 2020-2025 | Nexletol |
| Pfizer INC. | $138.81 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.66 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $118.61 | 2022-2023 | Optimizer |
| Intuitive Surgical, INC. | $117.12 | 2025 | |
| Amarin Pharma, INC. | $100.79 | 2019-2022 | |
| Novo Nordisk INC | $96.16 | 2023-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $90.80 | 2019-2021 | |
| Medtronic Vascular, INC. | $86.67 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $78.19 | 2019 | |
| Atricure, INC. | $64.33 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.06 | 2023-2025 | Lifevest |
| Lundbeck LLC | $45.97 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $43.87 | 2019-2021 | |
| Corcept Therapeutics | $38.09 | 2025 | Korlym |
| Arbor Pharmaceuticals, INC. | $36.11 | 2019-2021 | |
| Cordis US Corp. | $30.51 | 2022 | |
| Kestra Medical Technology Services, INC. | $26.03 | 2024 | Assure Wcd |
| Bardy Diagnostics, INC. | $25.00 | 2020-2021 | |
| Cardiovascular Systems INC. | $23.82 | 2021 | |
| Glaxosmithkline, LLC. | $23.22 | 2025 | Arexvy |
| Daiichi Sankyo INC. | $18.99 | 2023 | Injectafer |
| Acist Medical Systems, INC. | $18.27 | 2019 | |
| Baxter Healthcare | $15.36 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.